A Clinical Trial for the Interventional Robotic System
- Conditions
- Cerebral Angiography
- Interventions
- Device: Interventional Robotic System
- Registration Number
- NCT05778214
- Lead Sponsor
- Changhai Hospital
- Brief Summary
The goal of this multi-center clinical trial is to evaluate the efficacy and safety of the interventional robotic system for cerebral angiography, researchers will compare the ordinary angiography to assess the clinical success rate, operation time, radiation absorption, etc.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 142
- Age ≥ 18 and ≤ 85 years;
- Plan to undergo cerebral angiography;
- Voluntarily participated in this trial and signed the informed consent form.
- Preoperative mRS score >2;
- Allergy or intolerance to iodine contrast media;
- Allergy to interventional devices;
- Severe cardiac, hepatic and renal insufficiency;
- Active systemic infection;
- Severe stenosis, occlusion or skin infection at the puncture site;
- Subjects who are to undergo surgery at the same time as cerebral angiography;
- Subjects with severe coagulation disorders, bleeding tendencies, or contraindications to anticoagulant drugs (e.g., heparin);
- Subjects who are enrolled in clinical studies with other devices or drugs 3 months prior to screening;
- Female subjects of childbearing age who are pregnant or breastfeeding;
- Other subjects who, in the judgment of the investigator, are not suitable for participation in this trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Interventional Robotic System Assisted Surgery Interventional Robotic System Experimental group underwent cerebral angiography using the vascular interventional surgical control system
- Primary Outcome Measures
Name Time Method Clinical Success Rate at the end of surgery Assessment of the clinical success rate of the surgical physician in completing cerebral angiography examination through the operation of experimental instruments or artificial means.
- Secondary Outcome Measures
Name Time Method Super-selective Catheterization Time for Target Vessels at the end of surgery Calculate and compare the average time taken to perform super-selective catheterization for each target vessel during each surgical procedure.
Super-selective Technique Success Rate at the end of surgery Assessing the technical success rate of the surgical physician in performing super-selective catheterization of cerebral vessels through the operation of experimental instruments or artificial means.
Instrument Performance Evaluation at the end of surgery The surgical physician fills out a form after the surgery to subjectively evaluate the performance of the experimental instruments during the angiographic examination procedure.
DSA Fluoroscopy Time at the end of surgery Record and compare the duration of fluoroscopy during DSA for each surgical procedure.
Surgical Time at the end of surgery Record and compare the duration of each surgical procedure.
Primary Operator Radiation Absorbed Dose at the end of surgery Record and compare the absorbed dose of ionizing radiation received by the primary operator during each surgical procedure.
Trial Locations
- Locations (1)
Changhai Hospital
🇨🇳Shanghai, Shanghai City, China